Minerva Neurosciences, Inc (NERV): Price and Financial Metrics

Minerva Neurosciences, Inc (NERV)

Today's Latest Price: $3.46 USD

0.04 (1.17%)

Updated Jul 16 12:17pm

Add NERV to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 338 in Biotech

See all "A" rated Strong Buy stocks

NERV Daily Price Range
NERV 52-Week Price Range

NERV Stock Price Chart Technical Analysis Charts

NERV Price/Volume Stats

Current price $3.46 52-week high $15.22
Prev. close $3.42 52-week low $1.81
Day low $3.36 Volume 451,519
Day high $3.54 Avg. volume 1,779,635
50-day MA $6.56 Dividend yield N/A
200-day MA $6.60 Market Cap 135.70M

Minerva Neurosciences, Inc (NERV) Company Bio

Minerva Neurosciences, Inc. focuses on the development and commercialization of a portfolio of product candidates for the treatment of central nervous system diseases. The company was founded in 2007 and is based in Waltham, Massachusetts.

NERV Latest News Stream

Event/TimeNews Detail
Loading, please wait...

NERV Latest Social Stream

Loading social stream, please wait...

View Full NERV Social Stream

Latest NERV News From Around the Web

Below are the latest news stories about Minerva Neurosciences Inc that investors may wish to consider to help them evaluate NERV as an investment opportunity.

Minerva Neurosciences Exercises Right to Opt Out of Agreement With Janssen for Seltorexant (MIN-202)

Minerva Neurosciences, Inc. (NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, announced today that it has exercised its right to opt out of its agreement with Janssen Pharmaceutica NV (Janssen) for the future development of seltorexant (MIN-202). As a result, Minerva will now collect a royalty on worldwide sales of seltorexant in all indications in the mid-single digits, with no financial obligations to Janssen.

Yahoo | July 1, 2020

Hedge Fund Sentiment Is Stagnant On Minerva Neurosciences, Inc (NERV)

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful investors' positions as of the end of the first quarter. You can find articles about an individual hedge fund's trades on numerous financial […]

Yahoo | June 27, 2020

Do Options Traders Know Something About Minerva Neurosciences (NERV) Stock We Don't?

Investors need to pay close attention to Minerva Neurosciences (NERV) stock based on the movements in the options market lately.

Yahoo | June 22, 2020

Minerva Neurosciences (NERV) Looks Good: Stock Adds 8.4% in Session

Minerva Neurosciences (NERV) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

Zacks Investment Research | June 5, 2020

How Minerva Neurosciences (NERV) Stock Stands Out in a Strong Industry

Minerva Neurosciences (NERV) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

Zacks Investment Research | June 2, 2020

Read More 'NERV' Stories Here

NERV Price Returns

1-mo -8.47%
3-mo -49.71%
6-mo -58.61%
1-year -47.09%
3-year -57.80%
5-year -45.77%
YTD -51.34%
2019 5.49%
2018 11.40%
2017 -48.51%
2016 93.57%
2015 0.83%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.9139 seconds.